The present invention provides an anti-TWEAK receptor antibody that binds to the TWEAK receptor extracellular domain and reduces binding of TWEAK to the TWEAK receptor in the manufacture of a medicament for use in treating cancer in a subject. It also relates to an antibody and a method of making such an antibody.